Andere talen Alpha Cognition Inc. Toronto S.E.

Aandelen

ACOG

CA02074J2048

slotkoers Toronto S.E. Andere beurzen			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
- ^CAD	-.--%		-.--%	-.--%

04/04	Alpha Cognition's nettoverlies over het vierde kwartaal neemt iets toe ten opzichte van het voorgaande jaar	MT
04/04	Alpha Cognition Inc. Rapporteert resultaten voor het gehele jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Alpha Cognition's Q4 Comprehensive Loss Widens A Bit From Year Earlier Period	04/04
Alpha Cognition Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04/04
Alpha Cognition to Present at the Life Science Investor Forum March 7th	01/03
Alpha Cognition Files U.S. Patent Application Covering an ALPHA-1062 Oral Formulation to Treat Mild to Moderate Alzheimer’s Disease	22/02
Alpha Cognition Inc. Files Composition-Of-M Matter Patent	22/02
Alpha Cognition Provides Business Update	12/02
Alpha Cognition Announces Final Closing of Private Placement Offering and Completion of the Overallotment	19/01
Alpha Cognition Inc. announced that it has received $8.45 million in funding	19/01
Alpha Cognition Announces Fourth Closing of Private Placement and Continuation of the Offering	22/12
Alpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer's disease	08/12
Alpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease	07/12
Alpha Cognition Inc. Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-To-Moderate Alzheimer's Disease	07/12
Alpha Cognition Reports Amended Terms of Private Placement, Continuation of the Offering	05/12
Alpha Cognition Announces Amended Terms of Private Placement and Continuation of the Offering	05/12
Alpha Cognition Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11
Alpha Cognition Announces Third Closing of Private Placement and Continuation of the Offering	08/11
Alpha Cognition Announces Second Closing of Private Placement and Continuation of the Offering	16-10-23
Canadian Investment Regulatory Organization Trading Halt - ACOG.WT	02-10-23
Alpha Cognition Inc. Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer?s Disease	27-09-23
Alpha Cognition Announces Initial Closing of Private Placement and Pricing for Continuation of the Offering	01-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Alpha Cognition Inc. Toronto S.E.

Aandelen

ACOG

CA02074J2048

Andere talen

Filters